Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
eli lilly
life sciences
migraine
4
×
national
national blog main
national top stories
new york blog main
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan
amgen
biohaven
cancer
cancer immunotherapy
crispr
deals
What
new
4
×
approval
bio
class
companies
drug
drugs
fda
migraine
roundup
adults
allergan
approved
arguments
bails
big
biogen’s
biopharmaceutical
brand
bridgebio
capital
car
commercialized
competitors
convo
decades
develop
earlier
emerges
failures
firm
grab
headlines
ichnos
invest
life
littered
make
medicines
meeting
Language
unset
Current search:
migraine
×
new
×
" new york blog main "
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More